However, according to current knowledge, DAT imaging has not been confirmed to be suitable for the reliable differentiation of IPD and APS subtypes based on conventional quantitative analyses such as the DAT binding ratio (BR) quantification [4–6]. The gene discussed is SLC6A3; the disease is autoimmune polyendocrinopathy.